These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 296180)

  • 1. Appraisal of drug costs to hospitals.
    Salman L
    J Hosp Dent Pract; 1979; 13(1):5-9. PubMed ID: 296180
    [No Abstract]   [Full Text] [Related]  

  • 2. Generic prices expected to fall 3%.
    Matei D
    Hosp Mater Manage; 1990 Feb; 15(2):1, 8-10. PubMed ID: 10103550
    [No Abstract]   [Full Text] [Related]  

  • 3. Generics to save hospitals millions.
    Lutz S
    Mod Healthc; 1987 Nov; 17(24):42. PubMed ID: 10284685
    [No Abstract]   [Full Text] [Related]  

  • 4. Generics, private-labels may shake stagnant cephalosporin prices.
    Brightbill TC
    Hosp Mater Manage; 1987 Jun; 12(6):3-7. PubMed ID: 10283111
    [No Abstract]   [Full Text] [Related]  

  • 5. Hospitals hit with higher drug costs.
    Wagner M
    Mod Healthc; 1991 Mar; 21(10):16. PubMed ID: 10109612
    [No Abstract]   [Full Text] [Related]  

  • 6. Top generic prices fall 20% in competitive drug market.
    Brightbill T
    Hosp Mater Manage; 1988 Feb; 13(2):6-8. PubMed ID: 10318031
    [No Abstract]   [Full Text] [Related]  

  • 7. Which bottom line?
    Shane R
    Am J Hosp Pharm; 1991 Oct; 48(10):2130. PubMed ID: 1781465
    [No Abstract]   [Full Text] [Related]  

  • 8. Therapeutic substitution and better purchasing significantly reduce hospital pharmacy costs.
    Perry PA
    Hosp Mater Manage; 1990 Jan; 15(1):10-1. PubMed ID: 10103376
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacy: how cost-effective are generics?
    Wolfe H
    Hospitals; 1973 May; 47(9):100-8. PubMed ID: 4702078
    [No Abstract]   [Full Text] [Related]  

  • 10. Analysis of factors influencing antibiotic usage in hospitals.
    Sabath LD; Notto DA
    Prog Clin Biol Res; 1979; 35():65-74. PubMed ID: 538037
    [No Abstract]   [Full Text] [Related]  

  • 11. Marketplace. How drug company mergers affect HMOs and hospitals.
    Moskowitz DB
    Faulkner Grays Med Health; 1997 Jun; 51(23):suppl 2 p.. PubMed ID: 10167794
    [No Abstract]   [Full Text] [Related]  

  • 12. Generic drug prices fall 7%-24%; groups sort out manufacturers.
    Bernstein T
    Hosp Mater Manage; 1989 Feb; 14(2):8-10. PubMed ID: 10318186
    [No Abstract]   [Full Text] [Related]  

  • 13. A commentary on high-cost drugs.
    de Leon RF
    Curr Concepts Hosp Pharm Manage; 1989; 11(3):4-7. PubMed ID: 10318277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug costs can be defended.
    Lee AM
    Med Mark Media; 1982 Mar; 17(3):36, 38, 40 passim. PubMed ID: 10309584
    [No Abstract]   [Full Text] [Related]  

  • 15. Reform calls for new relationships.
    Black RC
    Healthc Exec; 1993; 8(3):25. PubMed ID: 10125603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hospital pharmacy and industry--conflict and collaboration.
    Gouveia WA
    Am J Hosp Pharm; 1984 Jul; 41(7):1391-4. PubMed ID: 6465157
    [No Abstract]   [Full Text] [Related]  

  • 17. Cost savings realized from interchanging ceftizoxime for cefoxitin.
    Guastella C
    Am J Hosp Pharm; 1988 Nov; 45(11):2376-7. PubMed ID: 3228095
    [No Abstract]   [Full Text] [Related]  

  • 18. Biotechnology drugs create new maze of concerns for hospitals.
    Lumsdon K
    Hospitals; 1991 Dec; 65(23):32, 34-5. PubMed ID: 1937456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Shades of gray. Secondary drug distributors raise questions.
    Lee J
    Mod Healthc; 2011 Oct; 41(41):10, 12. PubMed ID: 22111494
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacy management strategies for responding to hospital reimbursement changes.
    Curtiss FR
    Am J Hosp Pharm; 1983 Sep; 40(9):1489-92. PubMed ID: 6353913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.